Welcome: Guest

log in

Israel Business Forecast Q1 2007

Publication Date December 2006
Publisher Business Monitor
Product Type Report
Pages 42
ISBN Number not applicable
Product Code BMI00167
Buy this product or for assistance call +44 20 7060 7474

Summary

The Israel Business Forecast Q1 2007 report provides economic, financial, macroeconomic and political analysis for companies in Israel, helping them to formulate their budgets and business strategies to promote growth and profitability over the next 5 years. This business Forecast Q1 2007 involves a full investigation into Israel's economy and business environment, an essential tool for multinational companies, financial institutions and governments.

Content

  • Executive Summary
    • Focus On 2007
  • Chapter 1: Political Outlook
    • SWOT Analysis
    • BMI Political Risk Ratings
    • Political Outlook
    • Syria-Israel Reconciliation? Not Holding Our Breath
    • While we mooted the possibility of a rapprochement between Syria and Israel in our last Business Forecast
    • Report, we do not believe it is on the cards just yet
    • Table: Selected Cabinet List
    • Domestic Politics
    • Elections In 2007 Could Bring Back Bibi
    • We see a Likud victory over the next two years as more than plausible, given high levels of public discontent
    • with Prime Minister Ehud Olmert
  • Chapter 2: Economic Outlook
    • SWOT Analysis
    • BMI Economic Risk Ratings
    • Economic Activity
    • Growth To Stay Robust, Despite War, US Slowdown
    • Table: Economic Activity
    • Fiscal Policy
    • Revised Forecasts, Smaller Deficit Ahead
    • We remain sanguine about the official budget outlook, believing that the deficit will narrow gradually from
    • 2% of GDP to 05% of GDP over the forecast period However, we note that extra-budgetary spending on
    • 'non-recurrent' events such as the Gaza withdrawal or the war with Hizbollah could threaten the government's
    • capacity to service its debt
    • Table: Fiscal Indicators
    • Monetary Policy
    • Easing To Resume In H207
    • Strong growth figures underscore that there is little need to cut rates again, and the Bank of Israel will want
    • to avoid allowing the differential with the US to widen too far, suggesting a pause in the easing cycle for now
    • However, it should resume at some point in 2007
    • Debt Policy
    • Debt Targets Too Ambitious?
    • Although we believe a narrowing fiscal deficit will allow the government to reduce external debt gradually
    • from 246% of GDP to 226% of GDP over the forecast period, we are less confident about the finance minister's
    • aim to bring total debt down to 80% of GDP
    • Table: Monetary and Exchange Rate Indicators
    • Table: Debt Indicators
  • Chapter 3: Special Report
    • BMI Sovereign Risk Ratings
    • Table: BMI Sovereign RIsk Ratings
    • Middle East and Africa
    • Table: Middle East & Africa Sovereign Ratings - Evolution of Willingness to Pay
    • Table: Middle East & Africa Sovereign Ratings - Evolution of Ability to Pay
  • Chapter 4: Business Environment
    • SWOT Analysis
    • BMI Economic Risk Ratings
    • Legal Framework
    • Labour Force
    • Foreign Investment Policy
    • Table: Middle East & Africa, AnnualFDI Inflows
    • Table: Israel, Annual FDI Inflows
    • Foreign Trade Regime
    • Table: Top Export Destinations, US$mn
    • Tax Regime
  • Chapter 5: Key Sectors
    • Pharmaceuticals & Healthcare
    • Market Summary
    • Israel represents the most advanced pharmaceuticals sector in the Middle East At US$179, annual per
    • capita pharmaceutical spending is the highest in the region Growth in generics is likely to outstrip the
    • prescription market, and the sector is expected to account for about 186% of the market by 2010 The
    • over the counter (OTC) sector will also continue to develop, mainly due to gradual deregulation, rapidly
    • reaching US$324mn by 2010
    • Table: Drug Market Trends 2005-2010
    • Table: Prescription Market Forecasts By Therapeutic Segment
Product features / use
Scope Expert Insight/Opinion yes
Level General Industry Strategies yes
Data Detailed Market Forecasts yes
Profiles Profiles of Key Companies yes
Features Contains SWOT Analysis yes
Extra Info Consumer Trends Highlighted yes

Industry Events